NYSEMKT: NBYNovabay Pharmaceuticals Inc Earnings Dates, Reports, Calls
Novabay Pharmaceuticals earnings were -$22.1M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest NBY earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$26.6M, up 1,956.9% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, NBY reported annual earnings of -$22.1M, with 157.2% growth.
NBY earnings history
Current Revenue
$0.0
Current Earnings
-$22.1M
Current Profit Margin
0%
NBY Return on Equity
Current Company
N/A
Current Industry
-12.5%
Current Market
29.1%
NBY Return on Assets
Current Company
-302.2%
Current Industry
-8.3%
NBY is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance
Be the first to know when NBY announces earnings.
NBY Return on Capital Employed
Current Company
-280.51%
Current Industry
-2.4%
NBY's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance
NBY vs Biotech Stocks
Novabay Pharmaceuticals Earnings Reports & History FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.